Market Tracker

07/01 1:08pm ET
4.17
BATS BZX Real-Time Price
As of 1:07pm ET
 +0.12 / +2.96%
Today’s Change
2.61
Today|||52-Week Range
9.64
-8.15%
Year-to-Date
Why Agenus' Stock Has Stumbled in 2016
Jun 27 / MotleyFool.com - Paid Partner Content
Better Buy: Agenus Inc. vs. bluebird bio
Jun 24 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close4.05
Today’s open4.06
Day’s range4.04 - 4.26
Volume44,713
Average volume (3 months)1,162,982
Market cap$350.4M
Dividend yield--
Data as of 1:07pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-59.15%
Earnings growth (this year)-25.07%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+255.67%
P/E ratioNM
Price/Sales14.31
Price/Book4.95

Competitors

 Today’s
change
Today’s
% change
NDRMNeuroderm Ltd-0.20-1.23%
ONVOOrganovo Holdings In...+0.06+1.61%
CGENCompugen Ltd+0.15+2.31%
VYGRVoyager Therapeutics...+0.26+2.37%
Data as of 1:08pm ET, 07/01/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$24.8M
Annual profit (last year)-$87.9M
Net profit margin-354.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Garo H. Armen
Chief Financial Officer
Charles Evan Ballantyne
Corporate headquarters
Lexington, Massachusetts

Forecasts